Search
Medline Ord Shs Class A
MDLNAdd to Watchlist
38.750USD
+1.120+2.98%
Close 07-24 16:00（ET）Quotes delayed by 15 min
49.43BMarket Cap
32.68P/E TTM
Earnings Forecast
Currency: USD Updated:Analyst Rating
Based on
28
analysts
Buy
Current Rating
50.417
Target Price
+28.98%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
109
Total
7
Median
9
Average
Company name
Ratings
Analysts
Medline Ord Shs Class A
MDLN
28
Medtronic PLC
MDT
34
Stryker Corp
SYK
32
Dexcom Inc
DXCM
32
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
29
1
2
3
...
22
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Medline Ord Shs Class A's expected revenue for the next quarter?
Medline Ord Shs Class A's expected revenue is 7.72B.
How have Medline Ord Shs Class AMDLN's recent earnings per share performed?
The market expectation was USD 0.16, while Medline Ord Shs Class AMDLN's earnings per share (EPS) for the previous quarter was USD 0.21. EPS for the next quarter is expected at USD 0.39.
What is the analyst rating for Medline Ord Shs Class A?
Based on the ratings of Medline Ord Shs Class A's stock from 28 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.